GL1X · GenesisL1 explorer

MolNFT v1 · #124761 · protein

Discovery of tak-272: a novel, potent and orally active renin in- hibitor

5KOQ: “Discovery of tak-272: a novel, potent and orally active renin in- hibitor”. X-ray diffraction, 2 ligands (6VR, NAG), 6 pockets (best druggability 0.83). MolNFT v1 #124761 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5KOQ
Type
protein
Length
668 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Renin
EC
3.4.23.15
UniProt
P00797
Ligands
6VR, NAG
Pockets
6 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARenin (EC 3.4.23.15)protein33516% helix, 46% strandP00797
BRenin (EC 3.4.23.15)protein33316% helix, 45% strandP00797

Ligands and binding sites

  • 6VR · 2-~{tert}-butyl-4-(furan-2-ylmethylamino)-~{N}-(2-methylpropyl)-~{N}-[(3~{S})-piperidin-3-yl]pyrimidine-5-carboxamide · ligand · 2 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A, B
  • PEG · Di(hydroxyethyl)ether · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15300.830.8962empty
25830.750.82676VR
35060.640.76386VR
41600.530.8023empty
52160.500.7632empty

Interfaces

1 interface between chains.

  • A–B · 1123 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 5KOQ · Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.